Camille MacMillin/STAT

STAT+ | Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight

Yale secret shopper study of 49 telehealth sites reveals how easy it is to get GLP-1 prescriptions online, often with minimal medical oversight.

By Katie Palmer

STAT+ | I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned

Even if the biggest claims about the technology in biotech are hype, artificial intelligence may still have an immediate impact in the field.

By Matthew Herper

STAT+ | GOP lawmakers push Trump’s FDA to make sure clinical trials are diverse

Republicans include calls to promote diversity in clinical trials in new FDA funding bill. Move is based on a Biden-era law that's yet to be implemented.

By John Wilkerson

What does content creation do to mental health?

At Vidcon, the yearly social video creator conference, the mental health of content producers was a hot topic. STATus Report host Alex Hogan investigates.

By Alex Hogan

Opinion: The smart way to regulate the peptide boom

The FDA should take a middle-ground approach instead of outright banning popular but unproven peptides, writes former surgeon general.

By Jerome Adams

Opinion: Stopping doctors from ordering unnecessary diagnostic tests requires a structural fix

Diagnostic stewardship helps doctors better use tests to save money and protect patients from harm.

By Daniel Morgan